T1	Participants 12 108	patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era
T2	Participants 627 734	The 11 482 patients enrolled in the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial
